Global Hormone Replacement Therapy Market 2015-2019

2015-11-11
Price :
Published : Nov-2015
No. of Pages : 69

Global Hormone Replacement Therapy Market 2015-2019

Covering: An in-depth study of the global hormone replacement therapy market and segmentation by type of hormonal therapy (estrogen replacement therapy and growth hormone replacement therapy), by route of administration (oral, parenteral, and transdermal), and by geography (the Americas, EMEA, and APAC). The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market, including F. Hoffmann-La Roche, Merck Serono, Novartis, Novo Nordisk, and Pfizer.

An overview of the hormone replacement therapy market

Hormone replacement therapy involves the replacement of the hormones in the body whose levels have become low, in case of women nearing menopause or patient with growth hormone deficiency due to conditions such as dwarfism. At present, the combination of drugs are used to treat the conditions, which are known to have a better safety and efficacy parameter. Unmet medical needs is one of the major drivers influencing the growth of the market. Therefore, the need for new treatment options with better safety results to accommodate the current unmet need is huge.

In 2014, the Americas dominated the market, where the majority of the contribution was from the US, and this trend is expected to continue during the forecast period. However, the market in the APAC region is witnessing a rapid growth, hence, there is a vast opportunity for vendors to venture into this region. The expects the global hormone replacement therapy market to grow at a moderate rate, posting a CAGR of over 2% during the forecast period.

Segmentation of the hormone replacement therapy market by type of hormonal therapy

  • Estrogen replacement therapy
  • Growth hormone replacement therapy

With a market share of more than 60% the estrogen replacement therapy segment dominate the hormone replacement therapy market. Estrogen replacement therapy is a type of therapy in which estrogen hormones are commonly used to treat the symptoms of menopause. It helps in the reduction of short-term changes of menopause such as hot flashes, disturbed sleep, and vaginal dryness.

Segmentation of the hormone replacement therapy market by route of administration

  • Oral
  • Parenteral
  • Transdermal

The oral route of administration is a sub-division of enteral administration and is regarded as one of the safest and most preferred routes of drug administration. Some of the drug that are administered orally are Premarin and Estrace.

Competitive landscape and key vendors

The global hormone replacement therapy market is a mature market, which is extremely competitive due to the presence of a huge number of small and large vendors. Therefore, development of low-dose oral drugs and locally acting transdermal hormonal replacement products with high efficacy is expected to captivate the attention of players in the hormonal replacement market.

Key vendors in this market are -

  • F. Hoffmann-La Roche
  • Merck Serono
  • Novartis
  • Novo Nordisk
  • Pfizer

Other prominent vendors included in this report are Abbott Laboratories, Amgen, ANI Pharmaceuticals, Bayer, Eli Lilly, Hisamitsu Pharmaceutical, Ipsen, Merck, Mylan Laboratories, Orion, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries, and Therapeutics MD.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019?
  • What are the key factors driving the global hormone replacement therapy market?
  • What are the key market trends impacting the growth of the global hormone replacement therapy market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global hormone replacement therapy market?
  • What are the market opportunities and threats faced by the vendors in the global hormone replacement therapy market?
  • What are the trending factors influencing the market shares of the Americas, EMEA, and APAC?
  • What are the key outcomes of the five forces analysis of the global hormone replacement therapy market?
Filed in: Pharmaceutical, Therapeutics
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Global Weight Loss Supplemet Market 2016-2020

The global weight loss management market is growing at a fast rate. The major factors driving the growth include the rising number of obesity cases and growing awareness of lifestyle diseases. Increased government initiatives and a surge in health club memberships are expected to further drive the market. Dietary supplements include dietary ingredients such as minerals, amino acids, vitamins, herbs, and so on. The intake of these supplements adds nutritional value to the body, helping to reduce the risk of diseases. They are available in various forms such as powders, pills, tablets, liquids, and gel caps. The analysts forecast Global Weight Loss Supplement Market to grow at a CAGR of 5.3% during the period 2016-2020. Covered in this report The report covers the present scenari......
$2500

Global Contact Lens Market 2016-2020

Contact lenses are a replacement for corrective glasses due to their better aesthetic and cosmetic appeal. They are thin lenses that are placed directly on the surface of the eye and are worn to correct vision or for other therapeutic purposes. They are also worn for cosmetic reasons, particularly to change eye color. Contact lenses can be rigid, soft, or hybrid in nature, depending on the composition of the materials used. The advantages of contact lens over corrective glasses make them suitable to wear in any weather conditions, outdoor activities, or sports. The analysts forecast global contact lens market to grow at a CAGR of 6.63% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global contact lens m......
$2500

Global Intravenous Solutions Market 2016-2020

The infusion of liquid substances, such as nutrients and drugs, directly into a vein is referred as intravenous therapy. Intravenous fluids are extensively used to treat electrolyte imbalances, maintain fluid balance, and replace fluid losses. These fluids are dispensed in volumes ranging from 25-1,000 milliliters and are available in either plastic bags or glass bottles. A complete mixture of all essential nutrients is also available in multi-chamber bags, and these bags are gaining immense popularity among numerous end-users. The analysts forecast global intravenous solutions market to grow at a CAGR of 5.79% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global intravenous solutions market for 2016-2020......
$2500

Anticoagulants Market in the US 2016-2020

Anticoagulants have been used for over 80 years to treat clotting disorders. It is used as a first line of defense for disorders such as deep vein thrombosis (DVT), pulmonary embolism, AF, and acute coronary syndrome. With the advent of time, traditional therapies are replaced by novel oral anticoagulants, which have better safety and efficacy profiles. The 1990s saw rapid development in the field of direct thrombin inhibitors. Though these drugs, such as hirudin, have been in use from the early 19th century, they were accepted with the development of genetic engineering technology. The recombinant forms, such as desirudin, are also available in the market. During the same period, the focus shifted toward the development of factor Xa inhibitors, and by early 2000s, the first indirect fa......
$2500

Global Osteoarthritis Pain Drugs Market 2016-2020

Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. It is also known as degenerative joint disease, hypertrophic arthritis, and degenerative arthritis, and is most commonly prevalent in older (above 60 years of age) and middle-aged people (between 40-59 years of age). The exact etiology of osteoarthritis is not well understood, but is believed to be an outcome of mechanical and molecular events in the affected joint. Increasing age, obesity, overuse of the j......
$2500

Global Telecardiology Market 2016-2020

Telecardiology is the provision of diagnosis and health monitoring of cardiac patients by physicians and healthcare professional from a distant location with the help of ICT. It is the branch of telemedicine services, which focuses on treatment of cardiovascular diseases (CVDs). Telecardiology services enable healthcare professional to access cardiac data of patient such as cardiac test results in the form of text, images and videos. Using telecardiology, cardiology specialists can monitor patients' heart related data, ensuring quick identification of cardiac problems. During emergency, physicians can offer consultation and prescribe medicines via videoconferencing. Telecardiology technology services are also used for advanced CVDs research, training, and education. The analysts fore......
$2500

Global Teleradiology Market 2016-2020

The healthcare industry is witnessing phenomenal changes owing to increased adoption of digital health platforms such as mobile health, telehealth, EMR, and other wireless technologies. Digital health platforms have become essential elements in every healthcare organization, as they enable remote monitoring of patients, increase healthcare delivery efficiencies, improve access to electronic health information, and improve the quality of healthcare services along with reducing costs. Teleradiology is a comprehensive part of telehealth services. Teleradiology refers to the electronic transmission of radiological images via the internet for a second opinion or emergency services. Radiological images are obtained from techniques such as X-ray, CT, ultrasound, MRI, and nuclear imaging. Teler......
$2500

Global Postmenopausal Osteoporosis Drugs Market 2016-2020

Bones have the ability to grow and heal naturally, but changes in diet, exercise levels, and body chemistry lead to changes in the bone mineral density. This results in osteoporosis, which is characterized by low bone density and structural deterioration of bone tissues, leading to fragile bones. Rapid bone resorption or slow bone replacement can result in the development of the disease. Gender, age, body size (low body weight), ethnicity, and family history also play a role in developing osteoporosis. Other risk factors include medication, calcium and vitamin intake, alcohol intake, and smoking. Women are at a greater risk of developing osteoporosis than men as estrogens play an important role in maintaining bone strength. Small amounts of bone are lost as part of normal aging process,......
$2500

Global Home Healthcare Market 2016-2020

Home healthcare refers to a wide range of medical products (include heart rate monitors, blood glucose level indicators, and nebulizers), services, and solutions that provide health monitoring, treatment, and physical support to patients or customers at home. People do not need to visit a hospital or any other healthcare facility to benefit from these offerings; they can be accessed in the comfort of homes. The home healthcare market offers complete solutions that include the product as well as software and support from consultants and physicians. The analysts forecast Global Home Healthcare Market to grow at a CAGR of 8.85% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the Global Home Healthcare Market for ......
$2500

Global Non-alcoholic Steatohepatitis Market 2016-2020

NAFL disease, also known as fatty infiltration, is characterized by the accumulation of fat in the liver. It is of two types: NAFL and NASH. Fatty inflammation characterized by higher fat deposition than the normal level, 5%-10%, causes the disease. NASH causes severe inflammation of the liver, leading to damage of the organ. It is a benign condition of unknown etiology and is asymptomatic in nature during its initial stages, resulting in late diagnosis. Conditions such as obesity, diabetes, hyperlipidemia, insulin resistance, and toxicity by drugs such as amiodarone, tamoxifen, and perhexiline maleate can cause NASH. The analysts forecast global NASH market to grow at a CAGR of 24.58% during the period 2016-2020. Covered in this report The report covers the present scenario and t......
$2500